MA27889A1 - Comprime contenant de la fluvastatine et de la carmellose calcique - Google Patents

Comprime contenant de la fluvastatine et de la carmellose calcique

Info

Publication number
MA27889A1
MA27889A1 MA28679A MA28679A MA27889A1 MA 27889 A1 MA27889 A1 MA 27889A1 MA 28679 A MA28679 A MA 28679A MA 28679 A MA28679 A MA 28679A MA 27889 A1 MA27889 A1 MA 27889A1
Authority
MA
Morocco
Prior art keywords
carmellosis
calcium
tablet containing
fluvastatin
containing fluvastatin
Prior art date
Application number
MA28679A
Other languages
English (en)
Inventor
Tomoyuki Uehara
Kenji Taguchi
Kenichi Kitaoka
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA27889A1 publication Critical patent/MA27889A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention se rapporte à un comprimé contenant de la fluvastatine, en particulier à un comprimé contenant de la fluvastatine qui possède une excellente propriété de désintégration et une bonne biodisponibilité. Le comprimé contenant de la fluvastatine selon l'invention est caractérisé en ce qu'il renferme, comme agent de désintégration, de la carmellose calcique.
MA28679A 2003-06-25 2005-12-21 Comprime contenant de la fluvastatine et de la carmellose calcique MA27889A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003181349 2003-06-25

Publications (1)

Publication Number Publication Date
MA27889A1 true MA27889A1 (fr) 2006-05-02

Family

ID=33549526

Family Applications (1)

Application Number Title Priority Date Filing Date
MA28679A MA27889A1 (fr) 2003-06-25 2005-12-21 Comprime contenant de la fluvastatine et de la carmellose calcique

Country Status (21)

Country Link
US (1) US20090117181A1 (fr)
EP (1) EP1641440B1 (fr)
KR (1) KR20060030480A (fr)
CN (1) CN1809342A (fr)
AT (1) ATE471713T1 (fr)
AU (1) AU2004251439B2 (fr)
BR (1) BRPI0411855A (fr)
CA (1) CA2529447A1 (fr)
CO (1) CO5650224A2 (fr)
DE (1) DE602004027808D1 (fr)
EC (1) ECSP056238A (fr)
IL (1) IL172531A0 (fr)
IS (1) IS8249A (fr)
MA (1) MA27889A1 (fr)
MX (1) MXPA05013943A (fr)
NO (1) NO20060261L (fr)
NZ (1) NZ544119A (fr)
RU (1) RU2361582C2 (fr)
TN (1) TNSN05330A1 (fr)
WO (1) WO2005000276A1 (fr)
ZA (1) ZA200509930B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080094837A (ko) * 2006-02-24 2008-10-24 테바 파마슈티컬 인더스트리즈 리미티드 플루바스타틴 나트륨 약학 조성물
ES2806256T3 (es) * 2010-10-12 2021-02-17 Bayer Ip Gmbh Productos masticables blandos no basados en almidón
US9399064B2 (en) 2011-04-12 2016-07-26 Sawai Pharmaceutical Co., Ltd. Pitavastatin-containing preparation and method for producing same
CN102309452B (zh) * 2011-09-14 2013-01-23 海南美大制药有限公司 氟伐他汀钠脂质体固体制剂
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CN104069502B (zh) * 2013-03-29 2018-02-16 北京罗诺强施医药技术研发中心有限公司 复合骨架材料及其药物组合物
CN104095850B (zh) * 2013-04-03 2019-04-05 深圳信立泰药业股份有限公司 一种稳定的匹伐他汀钙药物组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
HU9203780D0 (en) * 1991-12-12 1993-03-29 Sandoz Ag Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
GB9703388D0 (en) * 1997-02-18 1997-04-09 Sandoz Yakuhin K K Tokyo Sykk Organic compounds
AR035016A1 (es) * 1999-08-25 2004-04-14 Takeda Chemical Industries Ltd Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
WO2001058491A1 (fr) * 2000-02-10 2001-08-16 Takeda Chemical Industries, Ltd. Medicament comprenant une combinaison
US20020025952A1 (en) * 2000-07-06 2002-02-28 American Home Products Corporation Combinations of statins, estrogens and estrogenic agents
WO2002030400A1 (fr) * 2000-10-06 2002-04-18 Takeda Chemical Industries, Ltd. Preparations solides

Also Published As

Publication number Publication date
EP1641440A1 (fr) 2006-04-05
ECSP056238A (es) 2006-04-19
EP1641440B1 (fr) 2010-06-23
AU2004251439B2 (en) 2008-09-11
DE602004027808D1 (de) 2010-08-05
RU2006101889A (ru) 2007-08-10
TNSN05330A1 (en) 2007-07-10
ATE471713T1 (de) 2010-07-15
RU2361582C2 (ru) 2009-07-20
CO5650224A2 (es) 2006-06-30
US20090117181A1 (en) 2009-05-07
NZ544119A (en) 2008-04-30
KR20060030480A (ko) 2006-04-10
NO20060261L (no) 2006-01-18
IS8249A (is) 2006-01-20
BRPI0411855A (pt) 2006-08-29
AU2004251439A1 (en) 2005-01-06
CN1809342A (zh) 2006-07-26
WO2005000276A1 (fr) 2005-01-06
CA2529447A1 (fr) 2005-01-06
IL172531A0 (en) 2006-04-10
ZA200509930B (en) 2007-01-31
MXPA05013943A (es) 2006-02-24

Similar Documents

Publication Publication Date Title
CR7076S (es) Recipiente
MA27889A1 (fr) Comprime contenant de la fluvastatine et de la carmellose calcique
UY30023A1 (es) Nueva asociacion de un inhibidor de la corriente sinusal i, y de un inhibidor calcico y las composiciones farmaceuticas que la contienen
NL1025055A1 (nl) Verbeterd lampontwerp.
ITFI20020246A1 (it) Contenitore sterile.
ES1051942Y (es) Canape modular.
NL1024812A1 (nl) Lampenkap.
ES1051309Y (es) Desmenuzador de especias.
ES1052333Y (es) Cajon premarco.
ES1053305Y (es) Columbario modular.
BR0202912B1 (pt) produto absorvente.
ES1053557Y (es) Luminaria vertical empotrable.
ES1052590Y (es) Quiosco-consigna.
ES1053053Y (es) Destoconador vertical.
ES1052628Y (es) Extintor instantaneo.
SE0202435D0 (sv) Lykta, särskilt gravlykta
ES1052131Y (es) Luminaria estanca mejorada.
ES1052944Y (es) Techo modular.
ITSS20020004A1 (it) Paella algherese.
ES1051247Y (es) Calzado de seguridad.
ES1052052Y (es) Brida.
MA25629A1 (fr) Reacteur : aero-hydro-electrique.
ES1053602Y (es) Cerradura de doble bombillo.
ITUD20020216A1 (it) Capriata componibile.
TW200500081A (en) Novel rotaviruses and use thereof